You are here
Systemic treatment with water-soluble corticosteroid phosphates
Pruritus ani - Systemic treatment with water-soluble corticosteroid phosphates Factor
Last reviewed for CCPS 30 June 1999.
Preliminary questions [16842]
17082 there is some evidence that systemic treatment with water soluble corticosteroid phosphates may be a factor in the development or worsening of the condition under consideration.
17027 the veteran has been systemically treated with water-soluble corticosteroid phosphates at some time.
17029 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and VEA service for pruritus ani.
17032 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and VEA service for the clinical onset of pruritus ani.
17034 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and operational service for the clinical onset of pruritus ani.
or
17035 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and eligible service for the clinical onset of pruritus ani.
or
16849 the clinical onset of the veteran's pruritus ani occurred after the end of the veteran's last period of VEA service. the veteran's pruritus ani permanently worsened. for the identified illness or injury, the veteran was being systemically treated with water-soluble corticosteroid phosphates within the 24 hours immediately before the clinical worsening of the condition under consideration. 17033 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and VEA service for the clinical worsening of pruritus ani. 17036 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and operational service for the clinical worsening of pruritus ani. or 17037 — the veteran has established the causal connection between the treatment with water-soluble corticosteroid phosphates and eligible service for the clinical worsening of pruritus ani. Clinical onset and operational service [17034] or 17038 — the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related to operational service. Clinical onset and eligible service [17035] 17039 — the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related to eligible service. Clinical worsening and operational service [17036] 17038 — the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related to operational service. Clinical worsening and eligible service [17037] 17039 — the identified illness or injury, for which the systemic treatment with water-soluble corticosteroid phosphates was given, is causally related to eligible service.